JPMorgan Chase & Co. increased its stake in Chimerix, Inc. (NASDAQ:CMRX) by 26.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,240 shares of the biopharmaceutical companys stock after purchasing an additional 5,926 shares during the period. JPMorgan Chase & Co.s holdings []
JPMorgan Chase & Co. reduced its stake in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) by 43.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 59,786 shares of the companys stock after selling 46,316 shares during the quarter. JPMorgan Chase & Co.s holdings in Cyclerion Therapeutics were []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE